Coraze Care
Coraze RF Care (probe·glove handpiece)
A hands-on radiofrequency care program that delivers Coraze RF energy through a probe and glove handpiece, gently massaged over the face, using warmth to boost firmness, circulation and a healthy glow.
What is it?
Radiofrequency (RF) current passes through the skin and creates deep heating. This warmth stimulates collagen remodeling and boosts blood and lymph circulation, leading to firmer skin, better tone and less puffiness. The practitioner applies it with a probe or a glove-type electrode in a massage-like motion, so compared with high-intensity lifting devices it feels warm and relaxing, with no pain and no downtime.
Who it's for
- Early care for loss of facial firmness and sagging, fine lines
- Dull, tired-looking skin → brightening and glow care
- Puffiness, poor circulation, cold-feeling skin
- Maintenance between more intensive lifting treatments
At Datena
- Probe + glove, 1 or 3 sessions / choice of roller, probe or glove / brightening glow care
- Remove metal accessories
Before treatment
- Let us know in advance if you have metal implants, a pacemaker or any other metal or electronic device in your body
- Not for pregnant women; areas with active infection or wounds are avoided
- Remove metal accessories from the treatment area
After treatment
- No downtime — you can wash your face and wear makeup the same day
- Hydrate and moisturize after the heat treatment; avoid saunas on the same day
Good to know
- Temporary redness and warmth (fades within a few hours)
- Rarely, sensitivity from heat stimulation
Pairs well with
- Probe + glove in 1- or 3-session packages, with a choice of roller, probe or glove
- Tone-Up & Glow Care Program
"Warm, hands-on radiofrequency — no pain" "Keep your firmness up between lifting treatments" "Brighter tone and glow the same day — texture & radiance care"
Results and recovery time vary depending on your skin. Pricing and the exact number of sessions will be explained during your consultation after diagnosis. Written based on in-clinic materials as of October 2026.
